Blog

Moffitt Cancer Center is among more than 75 sites participating in a national pilot project being conducted by the American Society of Clinical Oncology (ASCO) and the Association of Community Cancer Centers (ACCC) to test a research site self-assessment tool and an implicit bias training program focused on increasing racial and ethnic diversity among cancer […]

As clinical research professionals, we understand the value of patient-donated data. Clinical trials can be time-consuming and sometimes onerous for patients, so we owe it to patients to use their data to the fullest extent possible. There is a lot of emphasis on using real-world data in drug development, but data from clinical trials are […]

“Focus on building quality into the clinical trial process through proactive compliance rather than ‘inspecting’ quality in,” David Burrow, director of the Office of Scientific Investigations within the Office of Compliance at the U.S. Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER), told attendees of the ACRP 2021 virtual conference […]

Nearly half of attendees polled at the ACRP 2021 virtual conference yesterday (September 16) were either only “somewhat” (36%) or “not at all” (9%) prepared when the U.S. Food and Drug Administration (FDA) called to say an inspection was coming. The result wasn’t overly surprising to speaker Eric Pittman, director of the agency’s Bioresearch […]

Rutgers University has pioneered a decentralized approach to clinical trials that is allowing researchers to achieve better scientific outcomes as they accelerate the pace of finding cures, recruit lower-income and underrepresented populations that were previously unable to engage in clinical trials, and broaden the geographic coverage of studies. “This approach that speeds the process of […]